Below-knee amputation through a joint-sparing proximal tibial replacement for recurrent tumour.
We report a case which highlights the progression of osteofibrous dysplasia to adamantinoma and questions whether intralesional curettage is the appropriate treatment. The role of a joint-sparing massive endoprosthesis using cortical fixation is demonstrated and we describe a unique biomedical design which resulted in the manufacture of an end cap to allow amputation through a custom-made proximal tibial replacement, rather than an above-knee amputation following recurrence.
Spiegelberg
B G I
BG
Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex, UK. benspiegelberg@doctors.net.uk
Speigelberg
B G I
BG
Sewell
M D
MD
Coltman
T
T
Blunn
G W
GW
Flanagan
A M
AM
Cannon
S R
SR
Briggs
T W R
TW
D050398:Adamantinoma / Q000473:pathology / Q000601:surgery*; D000328:Adult; D000671:Amputation, Surgical / Q000379:methods*; D001848:Bone Diseases, Developmental / Q000473:pathology / Q000601:surgery*; D001859:Bone Neoplasms / Q000473:pathology / Q000601:surgery*; D003937:Diagnosis, Differential; D018450:Disease Progression; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery*; D010146:Pain / Q000601:surgery; D012865:Skiing / Q000293:injuries; D013978:Tibial Fractures / Q000150:complications